Nationally, only about 5% of cancer patients participate in clinical trials, with patients representing minorities participating even less. Even when eligible, nearly half of all patients decline participation when asked. The result? Slower accrual, abandonment of studies and less revenue from study sponsors.

To address this, we’ve created CareXplorer, a digital marketing campaign to activate patients into considering oncology clinical trial participation. We provide CareXplorer to oncology providers sites as a turnkey solution.

Digidence develops state-of-the-art software solutions for oncology practices to improve clinical trial accrual, patient outcomes and clinical workflow. Through collaborations across the United States, our products are expertly designed, scientifically tested, and fully utilized by clinicians and patients.